Hum Pathol 2011,42(10):1476–83.PubMedCrossRef 16. Li S, Jo YS, Lee JH, et al.: L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res 2009,15(23):7345–51.PubMedCrossRef 17. Kodera Y, Nakanishi H, Ito S, et al.: Expression

of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Anticancer Res selleck products 2009,29(10):4033–9.PubMed 18. Min JK, Kim JM, Li S, et al.: L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin Cancer Res 2010,16(14):3571–80.PubMedCrossRef 19. Tsutsumi S, Morohashi S, Kudo Y, et al.: L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic AR-13324 molecular weight ductal adenocarcinoma. J Surg Oncol 2011,103(7):669–73.PubMedCrossRef 20. Kato K, Maesawa C, Itabashi T, et al.: DNA hypomethylation at the CpG island is involved in

aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer. Int J Oncol 2009,35(3):467–76.PubMed 21. Shigdar S, Lin J, Yu Y, et al.: RNA aptamer click here against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci 2011,102(5):991–8.PubMedCrossRef 22. Kimura H, Kato H, Faried A, et al.: Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol 2007,30(1):171–9.PubMed 23. Fong D, Steurer M, Obrist P, et al.: Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol 2008,61(1):31–5.PubMedCrossRef 24. Went P, Vasei M, Bubendorf L, et al.: Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006,94(1):128–35.PubMedCrossRef 25. Wenqi D, Li W, Shanshan C, et al.: EpCAM is overexpressed in gastric cancer and its Adenylyl cyclase downregulation suppresses proliferation of gastric cancer. J Cancer Res Clin Oncol 2009,135(9):1277–85.PubMedCrossRef

26. Songun I, Litvinov SV, van de Velde CJ, et al.: Loss of Ep-CAM (CO17–1A) expression predicts survival in patients with gastric cancer. Br J Cancer 2005,92(9):1767–72.PubMedCrossRef 27. Akita H, Nagano H, Takeda Y, et al.: Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene 2011,30(31):3468–76.PubMedCrossRef 28. Saito H, Fukumoto Y, Osaki T, et al.: Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol 2007,14(5):1688–93.PubMedCrossRef 29. Hidaka H, Eto T, Maehara N, et al.: Comparative effect of lymph node metastasis classified by the anatomical site or by the number of nodes involved on prognosis of patients with gastric cancer. Hepatogastroenterology 2008,55(88):2269–2272.PubMed 30. Lauren P: The two histological main types of gastric cancer: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965, 64:31–9.PubMed 31.